These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8325974)

  • 21. Studies on the destruction of red blood cells. XII. Factors influencing the role of S hemoglobin in the pathologic physiology of sickle cell anemia and related disorders.
    GREENBERG MS; KASS EH; CASTLE WB
    J Clin Invest; 1957 Jun; 36(6 Part 1):833-43. PubMed ID: 13439023
    [No Abstract]   [Full Text] [Related]  

  • 22. Microvascular determinants of blood flow behavior and HbSS erythrocyte plugging in microcirculation.
    Baez S; Kaul DK; Nagel RL
    Blood Cells; 1982; 8(1):127-37. PubMed ID: 7115970
    [No Abstract]   [Full Text] [Related]  

  • 23. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
    Rodgers GP
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RBC adhesion to cremaster endothelum in mice with abnormal hemoglobin is increased by topical endotoxin.
    Liu XW; Pierangeli SS; Barker J; Wick TM; Hsu LL
    Ann N Y Acad Sci; 1998 Jun; 850():391-3. PubMed ID: 9668564
    [No Abstract]   [Full Text] [Related]  

  • 25. Modification of erythrocyte hydration in the treatment of sickle cell disease.
    Zhou GP; Anderson KP; Joiner CH; Gallagher PG
    Blood Cells Mol Dis; 2001; 27(1):65-8. PubMed ID: 11358362
    [No Abstract]   [Full Text] [Related]  

  • 26. Non-electrolyte permeability of deoxygenated sickle cells compared.
    Ellory JC; Sequeira R; Constantine A; Wilkins RJ; Gibson JS
    Blood Cells Mol Dis; 2008; 41(1):44-9. PubMed ID: 18456522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiologically based drug treatment of sickle cell disease.
    Steinberg MH
    Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythrocytic and vascular factors influencing the microcirculatory behavior of blood in sickle cell anemia.
    Kaul DK; Fabry ME; Nagel RL
    Ann N Y Acad Sci; 1989; 565():316-26. PubMed ID: 2672967
    [No Abstract]   [Full Text] [Related]  

  • 29. Sickle cell anemia: pathophysiologic aspects.
    Foster SB
    Heart Lung; 1974; 3(6):955-61. PubMed ID: 4497512
    [No Abstract]   [Full Text] [Related]  

  • 30. Sickle cell disease: a review and update of current therapy.
    Lawrenz DR
    J Oral Maxillofac Surg; 1999 Feb; 57(2):171-8. PubMed ID: 9973126
    [No Abstract]   [Full Text] [Related]  

  • 31. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
    Hebbel RP; Osarogiagbon R; Kaul D
    Microcirculation; 2004 Mar; 11(2):129-51. PubMed ID: 15280088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sickle cell anemia: a review for the pediatric dentist.
    da Fonseca M; Oueis HS; Casamassimo PS
    Pediatr Dent; 2007; 29(2):159-69. PubMed ID: 17566539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total body water, extracellular and plasma volume compartments in sickle cell anemia.
    Wilson WA; Alleyne GA
    West Indian Med J; 1976 Dec; 25(4):241-50. PubMed ID: 1014637
    [No Abstract]   [Full Text] [Related]  

  • 34. Water and electrolyte balance and kidney function in the sicle cell patient.
    Addae SK
    West Afr J Pharmacol Drug Res; 1974 Jan; 1(1):14P-19P. PubMed ID: 4470290
    [No Abstract]   [Full Text] [Related]  

  • 35. High oxygen environment during pregnancy rescues sickle cell anemia mice from prenatal death.
    Ye L; Chang JC; Lu R; Kan YW
    Blood Cells Mol Dis; 2008; 41(1):67-72. PubMed ID: 18207438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of red cell dehydration: a possible new treatment for sickle cell disease.
    Mueller BU; Brugnara C
    Pediatr Pathol Mol Med; 2001; 20(1):15-25. PubMed ID: 12673842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal permeability pathways in human red blood cells.
    Ellory JC; Robinson HC; Browning JA; Stewart GW; Gehl KA; Gibson JS
    Blood Cells Mol Dis; 2007; 39(1):1-6. PubMed ID: 17434766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sickle cell anemia 1910-1973. An overview.
    Lessin LS; Jensen WN
    Arch Intern Med; 1974 Apr; 133(4):529-32. PubMed ID: 4594392
    [No Abstract]   [Full Text] [Related]  

  • 39. Special issue of Microcirculation: examination of the vascular pathobiology of sickle cell anemia. Foreword.
    Hebbel RP
    Microcirculation; 2004 Mar; 11(2):99-100. PubMed ID: 15280085
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of Plasmodium falciparum growth in sickle cells in low oxygen environment and candle-jar.
    Orjih AU
    Acta Trop; 2005 Apr; 94(1):25-34. PubMed ID: 15777703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.